Role of transcription factor FOXM1 in diabetes and its complications (Review)
- Authors:
- Baoqing Zhao
- Mengxi Li
- Yanting Su
- Shigang Shan
- Wenbin Qian
- Dan Zhu
- Xiufen Liu
- Zhenwang Zhang
-
Affiliations: Hubei Key Laboratory of Diabetes and Angiopathy, Xianning Medical College, Hubei University of Science and Technology, Xianning, Hubei 437000, P.R. China, School of Nuclear Technology and Chemistry and Biology, Hubei University of Science and Technology, Xianning, Hubei 437000, P.R. China, School of Basic Medical Sciences, Xianning Medical College, Hubei University of Science and Technology, Xianning, Hubei 437000, P.R. China, School of Basic Medical Sciences, Xianning Medical College, Hubei University of Science and Technology, Xianning, Hubei 437000, P.R. China, Hubei Key Laboratory of Diabetes and Angiopathy, Xianning Medical College, Hubei University of Science and Technology, Xianning, Hubei 437000, P.R. China - Published online on: September 5, 2023 https://doi.org/10.3892/ijmm.2023.5304
- Article Number: 101
-
Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
 |
|
Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, Cavan D, Shaw JE and Makaroff LE: IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015-2040. Diabetes Res Clin Pract. 128:40–50. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Tomic D, Shaw JE and Magliano DJ: The burden and risks of emerging complications of diabetes mellitus. Nat Rev Endocrinol. 18:525–539. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Huang HK, Liu PP, Lin SM, Hsu JY, Yeh JI, Lai EC, Peng CC, Munir KM, Loh CH and Tu YK: Diabetes-Related complications and mortality in patients with atrial fibrillation receiving different oral anticoagulants: A nationwide analysis. Ann Intern Med. 175:490–498. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu S, Li J and Zhao X: Comparative risk of new-onset hyperkalemia for antihypertensive drugs in patients with diabetic nephropathy: A Bayesian network meta-analysis. Int J Clin Pract. 75:e139402021. View Article : Google Scholar | |
|
Kong L, Zhao H, Fan J, Wang Q, Li J, Bai J and Mao J: Predictors of frailty among Chinese community-dwelling older adults with type 2 diabetes: A cross-sectional survey. BMJ Open. 11:e0415782021. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Y, Wu G and Xu M: The effect of L-thyroxine substitution on oxidative stress in early-stage diabetic nephropathy patients with subclinical hypothyroidism: A randomized double-blind and placebo-controlled study. Int Urol Nephrol. 50:97–103. 2018. View Article : Google Scholar | |
|
Yao S, Fan LY and Lam EW: The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance. Semin Cancer Biol. 50:77–89. 2018. View Article : Google Scholar | |
|
Zhang Z, Liu W, Bao X, Sun T, Wang J, Li M and Liu C: USP39 facilitates breast cancer cell proliferation through stabilization of FOXM1. Am J Cancer Res. 12:3644–3661. 2022.PubMed/NCBI | |
|
Sawaya AP, Stone RC, Brooks SR, Pastar I, Jozic I, Hasneen K, O'Neill K, Mehdizadeh S, Head CR, Strbo N, et al: Deregulated immune cell recruitment orchestrated by FOXM1 impairs human diabetic wound healing. Nat Commun. 11:46782020. View Article : Google Scholar : PubMed/NCBI | |
|
Sawaya AP, Stone RC, Mehdizadeh S, Pastar I, Worrell S, Balukoff NC, Kaplan MJ, Tomic-Canic M and Morasso MI: FOXM1 network in association with TREM1 suppression regulates NET formation in diabetic foot ulcers. EMBO Rep. 23:e545582022. View Article : Google Scholar : PubMed/NCBI | |
|
Mondal A, Das S, Samanta J, Chakraborty S and Sengupta A: YAP1 induces hyperglycemic stress-mediated cardiac hypertrophy and fibrosis in an AKT-FOXM1 dependent signaling pathway. Arch Biochem Biophys. 722:1091982022. View Article : Google Scholar : PubMed/NCBI | |
|
Cao J, Jiang X and Peng X: Forkhead box M1 inhibits endothelial cell apoptosis and cell-cycle arrest through ROS generation. Int J Clin Exp Pathol. 11:4899–4907. 2018.PubMed/NCBI | |
|
Hamledari H, Sajjadi SF, Alikhah A, Boroumand MA and Behmanesh M: ASGR1 but not FOXM1 expression decreases in the peripheral blood mononuclear cells of diabetic atherosclerotic patients. J Diabetes Complications. 33:539–546. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Xu X, Zhang L, Hua F, Zhang C, Zhang C, Mi X, Qin N, Wang J, Zhu A, Qin Z and Zhou F: FOXM1-activated SIRT4 inhibits NF-κB signaling and NLRP3 inflammasome to alleviate kidney injury and podocyte pyroptosis in diabetic nephropathy. Exp Cell Res. 408:1128632021. View Article : Google Scholar | |
|
Yang Y, Zhang B, Yang Y, Peng B and Ye R: FOXM1 accelerates wound healing in diabetic foot ulcer by inducing M2 macrophage polarization through a mechanism involving SEMA3C/NRP2/Hedgehog signaling. Diabetes Res Clin Pract. 184:1091212022. View Article : Google Scholar | |
|
Gerst F, Kemter E, Lorza-Gil E, Kaiser G, Fritz AK, Nano R, Piemonti L, Gauder M, Dahl A, Nadalin S, et al: The hepatokine fetuin-A disrupts functional maturation of pancreatic beta cells. Diabetologia. 64:1358–1374. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Tabatabaei Dakhili SA, Perez DJ, Gopal K, Haque M, Ussher JR, Kashfi K and Velázquez-Martínez CA: SP1-independent inhibition of FOXM1 by modified thiazolidinediones. Eur J Med Chem. 209:1129022021. View Article : Google Scholar | |
|
Shirakawa J and Terauchi Y: Newer perspective on the coupling between glucose-mediated signaling and β-cell functionality. Endocr J. 67:1–8. 2020. View Article : Google Scholar | |
|
Ma J, Xing B, Cao Y, He X, Bennett KE, Tong C, An C, Hojnacki T, Feng Z, Deng S, et al: Menin-regulated Pbk controls high fat diet-induced compensatory beta cell proliferation. EMBO Mol Med. 13:e135242021. View Article : Google Scholar : PubMed/NCBI | |
|
Kohata M, Imai J, Izumi T, Yamamoto J, Kawana Y, Endo A, Sugawara H, Seike J, Kubo H, Komamura H, et al: Roles of FoxM1-driven basal β-cell proliferation in maintenance of β-cell mass and glucose tolerance during adulthood. J Diabetes Investig. 13:1666–1676. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Chen HY, Chen DT, Chiang YY, Lin SY and Lee CN: The correlation of forkhead box protein M1 (FOXM1) with gestational diabetes mellitus in maternal peripheral blood and neonatal umbilical cord blood. Taiwan J Obstet Gynecol. 61:652–656. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Detarya M, Thaenkaew S, Seubwai W, Indramanee S, Phoomak C, Saengboonmee C, Wongkham S and Wongkham C: High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma. Life Sci. 271:1191142021. View Article : Google Scholar : PubMed/NCBI | |
|
Peng G, Mosleh E, Yuhas A, Katada K, Cherry C and Golson ML: FOXM1 acts sexually dimorphically to regulate functional β-cell mass. bioRxiv. Jan 12–2023.Epub ahead of print. | |
|
Zhong L, Zhao Z, Hu Q, Li Y, Zhao W, Li C, Xu Y, Rong R, Zhang J, Zhang Z, et al: Identification of maturity-onset diabetes of the young caused by mutation in FOXM1 via whole-exome sequencing in Northern China. Front Endocrinol (Lausanne). 11:–534362. 2021. View Article : Google Scholar | |
|
Imai J: Regulation of compensatory β-cell proliferation by inter-organ networks from the liver to pancreatic β-cells. Endocr J. 65:677–684. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Imai J: Regulation of adaptive cell proliferation by vagal nerve signals for maintenance of whole-body homeostasis: Potential therapeutic target for insulin-deficient diabetes. Tohoku J Exp Med. 254:245–252. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Izumi T, Imai J, Yamamoto J, Kawana Y, Endo A, Sugawara H, Kohata M, Asai Y, Takahashi K, Kodama S, et al: Vagus-macrophage-hepatocyte link promotes post-injury liver regeneration and whole-body survival through hepatic FoxM1 activation. Nat Commun. 9:53002018. View Article : Google Scholar : PubMed/NCBI | |
|
Chen M, Zhao S, Guo WH, Zhu YP, Pan L, Xie ZW, Sun WL and Jiang JT: Maternal exposure to Di-n-butyl phthalate (DBP) aggravate gestational diabetes mellitus via FoxM1 suppression by pSTAT1 signalling. Ecotoxicol Environ Saf. 205:1111542020. View Article : Google Scholar : PubMed/NCBI | |
|
Shirakawa J, Tajima K, Okuyama T, Kyohara M, Togashi Y, De Jesus DF, Basile G, Kin T, Shapiro AMJ, Kulkarni RN and Terauchi Y: Luseogliflozin increases beta cell proliferation through humoral factors that activate an insulin receptor- and IGF-1 receptor-independent pathway. Diabetologia. 63:577–587. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Sun X, Luo LH, Feng L and Li DS: Down-regulation of lncRNA MEG3 promotes endothelial differentiation of bone marrow derived mesenchymal stem cells in repairing erectile dysfunction. Life Sci. 208:246–252. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Peng W, Zhu T, Xiang G, Ding T, Zhao J, Xiong D, Zhong Y and Zhang Y: Identification of signalling downstream of the transcription factor forkhead box protein M1 that protects against endoplasmic reticulum stress in a diabetic foot ulcer model. Diabet Med. 40:e150512023. View Article : Google Scholar : PubMed/NCBI | |
|
Zuppo DA, Missinato MA, Santana-Santos L, Li G, Benos PV and Tsang M: Foxm1 regulates cardiomyocyte proliferation in adult zebrafish after cardiac injury. Development. 150:dev2011632023. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Z, Li M, Sun T, Zhang Z and Liu C: FOXM1: Functional roles of FOXM1 in Non-Malignant diseases. Biomolecules. 13:8572023. View Article : Google Scholar : PubMed/NCBI | |
|
Filipsson K, Sundler F, Hannibal J and Ahren B: PACAP and PACAP receptors in insulin producing tissues: Localization and effects. Regul Pept. 74:167–175. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Ahren B: Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat Rev Drug Discov. 8:369–385. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang L, Jiang B, Zhu N, Tao M, Jun Y, Chen X, Wang Q and Luo C: Mitotic checkpoint kinase Mps1/TTK predicts prognosis of colon cancer patients and regulates tumor proliferation and differentiation via PKCα/ERK1/2 and PI3K/Akt pathway. Med Oncol. 37:52019. View Article : Google Scholar | |
|
Zheng J, Bu X, Wei X, Ma X and Zhao P: The role of FoxM1 in immune cells. Clin Exp Med. Mar 13–2023.Epub ahead of print. | |
|
Zhang H, Ackermann AM, Gusarova GA, Lowe D, Feng X, Kopsombut UG, Costa RH and Gannon M: The FoxM1 transcription factor is required to maintain pancreatic beta-cell mass. Mol Endocrinol. 20:1853–1866. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Mahmoodzadeh Sagheb M, Azarpira N, Mokhtary M, Hosseini SE and Yaghobi R: The effects of Leptin and Adiponectin on Pdx1, Foxm1, and PPARү Transcription in rat islets of langerhans. Hepat Mon. 13:e90552013. | |
|
Liu MN, Zhang L, Dong XY, Liu M, Cheng G, Zhang XL, He F and Wang GQ: Effects of Akkermansia muciniphila on the proliferation, apoptosis and insulin secretion of rat islet cell tumor cells. Sichuan Da Xue Xue Bao Yi Xue Ban. 51:13–17. 2020.In Chinese. PubMed/NCBI | |
|
Saavedra-García P, Nichols K, Mahmud Z, Fan LY and Lam EW: Unravelling the role of fatty acid metabolism in cancer through the FOXO3-FOXM1 axis. Mol Cell Endocrinol. 462(Pt B): 82–92. 2018. View Article : Google Scholar | |
|
Yamamoto J, Imai J, Izumi T, Takahashi H, Kawana Y, Takahashi K, Kodama S, Kaneko K, Gao J, Uno K, et al: Neuronal signals regulate obesity induced β-cell proliferation by FoxM1 dependent mechanism. Nat Commun. 8:19302017. View Article : Google Scholar | |
|
Imai J and Katagiri H: Regulation of systemic metabolism by the autonomic nervous system consisting of afferent and efferent innervation. Int Immunol. 34:67–79. 2022. View Article : Google Scholar | |
|
Shang R, Wang M, Dai B, Du J, Wang J, Liu Z, Qu S, Yang X, Liu J, Xia C, et al: Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway. Mol Oncol. 14:1381–1396. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Yang Y, Cai Z, Pan Z, Liu F, Li D, Ji Y, Zhong J, Luo H, Hu S, Song L, et al: Rheb1 promotes glucose-stimulated insulin secretion in human and mouse β-cells by upregulating GLUT expression. Metabolism. 123:1548632021. View Article : Google Scholar | |
|
Heo YJ, Choi SE, Jeon JY, Han SJ, Kim DJ, Kang Y, Lee KW and Kim HJ: Visfatin induces inflammation and insulin resistance via the NF-κB and STAT3 signaling pathways in hepatocytes. J Diabetes Res. 2019:40216232019. View Article : Google Scholar | |
|
Alaaeldin R, Abdel-Rahman IAM, Hassan HA, Youssef N, Allam AE, Abdelwahab SF, Zhao QL and Fathy M: Carpachromene ameliorates insulin resistance in HepG2 cells via modulating IR/IRS1/PI3k/Akt/GSK3/FoxO1 pathway. Molecules. 26:76292021. View Article : Google Scholar : PubMed/NCBI | |
|
Gao W, Du X, Lei L, Wang H, Zhang M, Wang Z and Li X, Liu G and Li X: NEFA-induced ROS impaired insulin signalling through the JNK and p38MAPK pathways in non-alcoholic steatohepatitis. J Cell Mol Med. 22:3408–3422. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Shrestha S, Kumar Singh V, Kumar Sarkar S, Shanmugasundaram B, Jeevaratnam K and Chandra Koner B: Effect of sub-toxic exposure to Malathion on glucose uptake and insulin signaling in L6 myoblast derived myotubes. Drug Chem Toxicol. 43:663–670. 2020. View Article : Google Scholar | |
|
Saltiel AR: Insulin signaling in health and disease. J Clin Invest. 131:e1422412021. View Article : Google Scholar : PubMed/NCBI | |
|
Zarrouki B, Benterki I, Fontés G, Peyot ML, Seda O, Prentki M and Poitout V: Epidermal growth factor receptor signaling promotes pancreatic β-cell proliferation in response to nutrient excess in rats through mTOR and FOXM1. Diabetes. 63:982–993. 2014. View Article : Google Scholar : | |
|
Zhao C, Chen HY, Zhao F, Feng HJ and Su JP: Acylglycerol kinase promotes paclitaxel resistance in nasopharyngeal carcinoma cells by regulating FOXM1 via the JAK2/STAT3 pathway. Cytokine. 148:1555952021. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Lu L, Tu J, Zhang J, Xiong T, Fan W, Wang J, Li M, Chen Y, Steggerda J, et al: Reciprocal regulation between forkhead box M1/NF-κB and methionine adenosyltransferase 1A drives liver cancer. Hepatology. 72:1682–1700. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Bodis K and Roden M: Energy metabolism of white adipose tissue and insulin resistance in humans. Eur J Clin Invest. 48:e130172018. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng S, Chen N, Kang X, Hu Y and Shi S: Irisin alleviates FFA induced β-cell insulin resistance and inflammatory response through activating PI3K/AKT/FOXO1 signaling pathway. Endocrine. 75:740–751. 2022. View Article : Google Scholar | |
|
Zhang Q, Kong X, Yuan H, Guan H, Li Y and Niu Y: Mangiferin improved palmitate-induced-insulin resistance by promoting free fatty acid metabolism in HepG2 and C2C12 cells via PPARα: Mangiferin improved insulin resistance. J Diabetes Res. 2019:20526752019. View Article : Google Scholar | |
|
Choi HJ, Jhe YL, Kim J, Lim JY, Lee JE, Shin MK and Cheong JH: FoxM1-dependent and fatty acid oxidation-mediated ROS modulation is a cell-intrinsic drug resistance mechanism in cancer stem-like cells. Redox Biol. 36:1015892020. View Article : Google Scholar : PubMed/NCBI | |
|
Longo M, Zatterale F, Naderi J, Parrillo L, Formisano P, Raciti GA, Beguinot F and Miele C: Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int J Mol Sci. 20:23582019. View Article : Google Scholar : PubMed/NCBI | |
|
Tian S, Lei I, Gao W, Liu L, Guo Y, Creech J, Herron TJ, Xian S, Ma PX, Eugene Chen Y, et al: HDAC inhibitor valproic acid protects heart function through Foxm1 pathway after acute myocardial infarction. EBioMedicine. 39:83–94. 2019. View Article : Google Scholar : | |
|
Tang SCW and Yiu WH: Innate immunity in diabetic kidney disease. Nat Rev Nephrol. 16:206–222. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Vaidya VS, Niewczas MA, Ficociello LH, Johnson AC, Collings FB, Warram JH, Krolewski AS and Bonventre JV: Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase. Kidney Int. 79:464–470. 2011. View Article : Google Scholar | |
|
Alicic RZ, Johnson EJ and Tuttle KR: Inflammatory mechanisms as new biomarkers and therapeutic targets for diabetic kidney disease. Adv Chronic Kidney Dis. 25:181–191. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Nastase MV, Zeng-Brouwers J, Beckmann J, Tredup C, Christen U, Radeke HH, Wygrecka M and Schaefer L: Biglycan, a novel trigger of Th1 and Th17 cell recruitment into the kidney. Matrix Biol. 68-69:293–317. 2018. View Article : Google Scholar | |
|
Xie H, Miao N, Xu D, Zhou Z, Ni J, Yin F, Wang Y, Cheng Q, Chen P, Li J, et al: FoxM1 promotes Wnt/β-catenin pathway activation and renal fibrosis via transcriptionally regulating multi-Wnts expressions. J Cell Mol Med. 25:1958–1971. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu-Ge D, Yang YP and Jiang ZJ: Knockdown CRNDE alleviates LPS-induced inflammation injury via FOXM1 in WI-38 cells. Biomed Pharmacother. 103:1678–1687. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou M, Shi J, Lan S and Gong X: FOXM1 regulates the proliferation, apoptosis and inflammatory response of keratinocytes through the NF-κB signaling pathway. Hum Exp Toxicol. 40:1130–1140. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Song S, Zhang R, Cao W, Fang G, Yu Y, Wan Y, Wang C, Li Y and Wang Q: Foxm1 is a critical driver of TGF-β-induced EndMT in endothelial cells through Smad2/3 and binds to the Snail promoter. J Cell Physiol. 234:9052–9064. 2019. View Article : Google Scholar | |
|
Chen Y, Li Y, Xue J, Gong A, Yu G, Zhou A, Lin K, Zhang S, Zhang N, Gottardi CJ and Huang S: Wnt-induced deubiquitination FoxM1 ensures nucleus β-catenin transactivation. EMBO J. 35:668–684. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Xie H, Gao YM, Zhang YC, Jia MW, Peng F, Meng QH and Wang YC: Low let-7d exosomes from pulmonary vascular endothelial cells drive lung pericyte fibrosis through the TGFβRI/FoxM1/Smad/β-catenin pathway. J Cell Mol Med. 24:13913–13926. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Jalgaonkar MP, Parmar UM, Kulkarni YA and Oza MJ: SIRT1-FOXOs activity regulates diabetic complications. Pharmacol Res. 175:1060142022. View Article : Google Scholar | |
|
Inoue Y, Moriwaki K, Ueda Y, Takeuchi T, Higuchi K and Asahi M: Elevated O-GlcNAcylation stabilizes FOXM1 by its reduced degradation through GSK-3β inactivation in a human gastric carcinoma cell line, MKN45 cells. Biochem Biophys Res Commun. 495:1681–1687. 2018. View Article : Google Scholar | |
|
Behl T, Wadhwa M, Sehgal A, Singh S, Sharma N, Bhatia S, Al-Harrasi A, Aleya L and Bungau S: Mechanistic insights into the role of FOXO in diabetic retinopathy. Am J Transl Res. 14:3584–3602. 2022.PubMed/NCBI | |
|
Sengupta A, Kalinichenko VV and Yutzey KE: FoxO1 and FoxM1 transcription factors have antagonistic functions in neonatal cardiomyocyte cell-cycle withdrawal and IGF1 gene regulation. Circ Res. 112:267–277. 2013. View Article : Google Scholar | |
|
Ioannou K: Diabetic nephropathy: Is it always there? Assumptions, weaknesses and pitfalls in the diagnosis. Hormones (Athens). 16:351–361. 2017. | |
|
Sanajou D, Ghorbani Haghjo A, Argani H and Aslani S: AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions. Eur J Pharmacol. 833:158–164. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Tziomalos K and Athyros VG: Diabetic Nephropathy: New risk factors and improvements in diagnosis. Rev Diabet Stud. 12:110–118. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Qi C, Mao X, Zhang Z and Wu H: Classification and differential diagnosis of diabetic nephropathy. J Diabetes Res. 2017:86371382017. View Article : Google Scholar : PubMed/NCBI | |
|
Sinha S, Dwivedi N, Woodgett J, Tao S, Howard C, Fields TA, Jamadar A and Rao R: Glycogen synthase kinase-3β inhibits tubular regeneration in acute kidney injury by a FoxM1-dependent mechanism. FASEB J. 34:13597–13608. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Chang-Panesso M, Kadyrov FF, Lalli M, Wu H, Ikeda S, Kefaloyianni E, Abdelmageed MM, Herrlich A, Kobayashi A and Humphreys BD: FOXM1 drives proximal tubule proliferation during repair from acute ischemic kidney injury. J Clin Invest. 129:5501–5517. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Zhou Q, Tang R, Huang Y and He T: FoxM1 inhibition ameliorates renal interstitial fibrosis by decreasing extracellular matrix and epithelial-mesenchymal transition. J Pharmacol Sci. 143:281–289. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Yu W, Wang G, Li LX, Zhang H, Gui X, Zhou JX, Calvet JP and Li X: Transcription factor FoxM1 promotes cyst growth in PKD1 mutant ADPKD. Hum Mol Genet. 32:1114–1126. 2023. View Article : Google Scholar | |
|
Halasi M and Gartel AL: Targeting FOXM1 in cancer. Biochem Pharmacol. 85:644–652. 2013. View Article : Google Scholar | |
|
Liao GB, Li XZ, Zeng S, Liu C, Yang SM, Yang L, Hu CJ and Bai JY: Regulation of the master regulator FOXM1 in cancer. Cell Commun Signal. 16:572018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu X, Yu M, Wang K, Zou W and Zhu L: FoxM1 affects adhesive, migratory, and invasive abilities of human retinoblastoma Y-79 cells by targeting matrix metalloproteinase 2. Acta Biochim Biophys Sin (Shanghai). 52:294–301. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu X, Xue L, Yao Y, Wang K, Tan C, Zhuang M, Zhou F and Zhu L: The FoxM1-ABCC4 axis mediates carboplatin resistance in human retinoblastoma Y-79 cells. Acta Biochim Biophys Sin (Shanghai). 50:914–920. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang RT, Miao RC, Zhang X, Yang GH, Mu YP, Zhang ZY, Qu K and Liu C: Fork head box M1 regulates vascular endothelial growth factor-A expression to promote the angiogenesis and tumor cell growth of gallbladder cancer. World J Gastroenterol. 27:692–707. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Cheng C, Wang S, Xu M, Zhang D and Zeng W: Knockdown of FOXM1 inhibits activation of keloid fibroblasts and extracellular matrix production via inhibition of TGF-β1/Smad pathway. Life Sci. 232:1166372019. View Article : Google Scholar | |
|
Mencalha AL, Binato R, Ferreira GM, Du Rocher B and Abdelhay E: Forkhead box M1 (FoxM1) gene is a new STAT3 transcriptional factor target and is essential for proliferation, survival and DNA repair of K562 cell line. PLoS One. 7:e481602012. View Article : Google Scholar : PubMed/NCBI | |
|
Imai J, Katagiri H, Yamada T, Ishigaki Y, Suzuki T, Kudo H, Uno K, Hasegawa Y, Gao J, Kaneko K, et al: Regulation of pancreatic beta cell mass by neuronal signals from the liver. Science. 322:1250–1254. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B and Anversa P: Myocardial cell death in human diabetes. Circ Res. 87:1123–1132. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Dai Z, Zhu MM, Peng Y, Jin H, Machireddy N, Qian Z, Zhang X and Zhao YY: Endothelial and Smooth muscle cell interaction via FoxM1 Signaling mediates vascular remodeling and pulmonary hypertension. Am J Respir Crit Care Med. 198:788–802. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Li Y, Feng J, Liu W, Li Y, Liu J, Yin Q, Lian H, Liu L and Nie Y: Mydgf promotes Cardiomyocyte proliferation and Neonatal Heart regeneration. Theranostics. 10:9100–9112. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Eltoft A, Arntzen KA, Wilsgaard T, Mathiesen EB and Johnsen SH: Interleukin-6 is an independent predictor of progressive atherosclerosis in the carotid artery: The Tromso Study. Atherosclerosis. 271:1–8. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Li H, Horke S and Forstermann U: Vascular oxidative stress, nitric oxide and atherosclerosis. Atherosclerosis. 237:208–219. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Nahrendorf M and Swirski FK: Cholesterol, CCR2, and monocyte phenotypes in atherosclerosis. Eur Heart J. 38:1594–1596. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Balli D, Ren X, Chou FS, Cross E, Zhang Y, Kalinichenko VV and Kalin TV: Foxm1 transcription factor is required for macrophage migration during lung inflammation and tumor formation. Oncogene. 31:3875–3888. 2012. View Article : Google Scholar : | |
|
Lok GT, Chan DW, Liu VW, Hui WW, Leung TH, Yao KM and Ngan HY: Aberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells. PLoS One. 6:e237902011. View Article : Google Scholar : PubMed/NCBI | |
|
Xie Y, Cui D, Sui L, Xu Y, Zhang N, Ma Y, Li Y and Kong Y: Induction of forkhead box M1 (FoxM1) by EGF through ERK signaling pathway promotes trophoblast cell invasion. Cell Tissue Res. 362:421–430. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Brem H and Tomic-Canic M: Cellular and molecular basis of wound healing in diabetes. J Clin Invest. 117:1219–1222. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Armstrong DG, Swerdlow MA, Armstrong AA, Conte MS, Padula WV and Bus SA: Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer. J Foot Ankle Res. 13:162020. View Article : Google Scholar : PubMed/NCBI | |
|
Soo BP, Rajbhandari S, Egun A, Ranasinghe U, Lahart IM and Pappachan JM: Survival at 10 years following lower extremity amputations in patients with diabetic foot disease. Endocrine. 69:100–106. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Smirnov A, Panatta E, Lena A, Castiglia D, Di Daniele N, Melino G and Candi E: FOXM1 regulates proliferation, senescence and oxidative stress in keratinocytes and cancer cells. Aging (Albany NY). 8:1384–1397. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y and Zychlinsky A: Neutrophil extracellular traps kill bacteria. Science. 303:1532–1535. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Lood C, Blanco LP, Purmalek MM, Carmona-Rivera C, De Ravin SS, Smith CK, Malech HL, Ledbetter JA, Elkon KB and Kaplan MJ: Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med. 22:146–153. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Carrasco K, Boufenzer A, Jolly L, Le Cordier H, Wang G, Heck AJ, Cerwenka A, Vinolo E, Nazabal A, Kriznik A, et al: TREM-1 multimerization is essential for its activation on monocytes and neutrophils. Cell Mol Immunol. 16:460–472. 2019. View Article : Google Scholar : | |
|
Palmer WC and Patel T: Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol. 57:69–76. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
de Beer JC and Liebenberg L: Does cancer risk increase with HbA1c, independent of diabetes? Br J Cancer. 110:2361–2368. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Hosokawa T, Kurosaki M, Tsuchiya K, Matsuda S, Muraoka M, Suzuki Y, Tamaki N, Yasui Y, Nakata T, Nishimura T, et al: Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy. World J Gastroenterol. 19:249–257. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Casagrande V, Mauriello A, Anemona L, Mavilio M, Iuliani G, De Angelis L, D'Onofrio M, Arisi I, Federici M and Menghini R: Timp3 deficiency affects the progression of DEN-related hepatocellular carcinoma during diet-induced obesity in mice. Acta Diabetol. 56:1265–1274. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Andrei LG: Thiazole antibiotics siomycin a and thiostrepton inhibit the transcriptional activity of FOXM1. Front Oncol. 3:1502013. | |
|
Shirakawa J, Fernandez M, Takatani T, El Ouaamari A, Jungtrakoon P, Okawa ER, Zhang W, Yi P, Doria A and Kulkarni RN: Insulin signaling regulates the FoxM1/PLK1/CENP-A pathway to promote adaptive pancreatic β cell proliferation. Cell Metab. 25:868–882 e5. 2017. View Article : Google Scholar | |
|
Ma Y, Wang X, Peng Y and Ding X: Forkhead box O1 promotes INS-1 cell apoptosis by reducing the expression of CD24. Mol Med Rep. 13:2991–2998. 2016. View Article : Google Scholar : PubMed/NCBI |
